Diana Richardson, MD
Assistant Clinical Professor, Neurology; Director, National VA Parkinson Disease Consortium , West Haven
Research & Publications
Biography
Research Summary
Dr. Richardson has been an investigator in clinical trials on Parkinson's Disease, Tremor, Cervical Dystonia and Botulinum Toxins. Currently she is the lead investigator for trials focused on Agent Orange associated Parkinson's Disease.
Selected Publications
- IncobotulinumtoxinA in Restless Legs Syndrome (RLS) – a Randomized Double Blind Cross Over Study (P3.029)Machado D, Richardson D, Jabbari B. IncobotulinumtoxinA in Restless Legs Syndrome (RLS) – a Randomized Double Blind Cross Over Study (P3.029). Neurology 2017, 88 DOI: 10.1212/wnl.88.16_supplement.p3.029.
- Botulinum Toxin Treatment of Chronic Migraine - A Double Blind Study with a Novel Technique Employing Fewer Injections. (P4.124)Richardson D, Jabbari B. Botulinum Toxin Treatment of Chronic Migraine - A Double Blind Study with a Novel Technique Employing Fewer Injections. (P4.124). Neurology 2016, 86 DOI: 10.1212/wnl.86.16_supplement.p4.124.
- Botulinum Toxin Treatment of Essential Tremor - A Customized Approach (S27.002)Rostami R, Chow C, Richardson D, Jabbari B, Machado D. Botulinum Toxin Treatment of Essential Tremor - A Customized Approach (S27.002). Neurology 2016, 86 DOI: 10.1212/wnl.86.16_supplement.s27.002.
- A Double Blind Investigation of Efficacy and Safety of IncobotulinumtoxinA in Parkinson Disease Tremor- A Customized Injection Approach (S40.007)Mittal S, Rostami R, Machado D, Richardson D, Jabbari B. A Double Blind Investigation of Efficacy and Safety of IncobotulinumtoxinA in Parkinson Disease Tremor- A Customized Injection Approach (S40.007). Neurology 2016, 86 DOI: 10.1212/wnl.86.16_supplement.s40.007.
- Incobotulinum toxin-A (inco-A) in restless legs syndrome (RLS) - a randomized double blind cross over study (P7.295)Rostami R, Machado D, Richardson D, Jabbari B. Incobotulinum toxin-A (inco-A) in restless legs syndrome (RLS) - a randomized double blind cross over study (P7.295). Neurology 2015, 84 DOI: 10.1212/wnl.84.14_supplement.p7.295.
- Focal Injection of Incobotulinum Toxin A Improves Refractory Local Cancer Pain at the Site of Radiation/Surgery (P3.315)Rostami R, Machado D, Richardson D, Jabbari B. Focal Injection of Incobotulinum Toxin A Improves Refractory Local Cancer Pain at the Site of Radiation/Surgery (P3.315). Neurology 2014, 82 DOI: 10.1212/wnl.82.10_supplement.p3.315.